Intellia Therapeutics
The National Account Director – Commercial Payers at Intellia shapes and executes the U.S. market access strategy with national commercial payers in preparation for the first gene editing therapy launch. This role focuses on building relationships with key payer stakeholders, communicating product value, and securing favorable coverage and reimbursement pathways.
Headquarters
Cambridge, Massachusetts, United States
Company Size
501-1000 employees
Founded
2014
Intellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
1 week ago
Intellia Therapeutics: Why The Clinical Hold Lift Isn't A Total Victory (NASDAQ:NTLA)
3 days ago
Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Intellia Therapeutics.
134% above the average for this role
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
2 weeks ago
National Account Executive
Genetix Biotherapeutics
Director, National Payer Accounts
Compass Pathways
Senior Director, Payer Accounts
Immatics
National Account Executive
Genetix Biotherapeutics
Senior Director, National Commercial Account Management
Compass Pathways
National Account Manager
Brinova Fastigheter AB